Pediatric patients deserve access to the most innovative treatments, but how do we overcome the unique challenges of implementing advanced therapies like gene, cell, and tissue treatments in children?
On May 23, 2025, at Wintercircus Ghent, ‘Next-gen Therapies for Next-gen Patients’ brings together leading clinical experts in the field with academic, industry and regulatory stakeholders to discuss recent innovations and address key issues such as cross-border access, data collection, reimbursement, and the regulatory landscape in Belgium. The symposium features keynote addresses by Gloria Ghéquière (cabinet Vandenbroucke) on fostering access to ATMPs in Belgium and Europe, and Prof. Dr. Arjan Lankester (Leiden University Medical Center) on the journey from pre-clinical development to cross-border gene therapy.
Through in-depth presentations and engaging discussions, we aim to inspire innovation and collaboration to shape the future of pediatric ATMPs in Belgium.